4//SEC Filing
Pletcher Brett A 4
Accession 0001127602-22-009215
CIK 0000882095other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 9:46 PM ET
Size
13.3 KB
Accession
0001127602-22-009215
Insider Transaction Report
Form 4
Pletcher Brett A
EVP, Gen Counsel & Corp Sec
Transactions
- Exercise/Conversion
Restricted Stock Unit
2022-03-10−2,593→ 20,431 total→ Common Stock (2,593 underlying) - Exercise/Conversion
Common Stock
2022-03-10+2,593→ 35,169 total - Exercise/Conversion
Common Stock
2022-03-10+3,130→ 38,299 total - Tax Payment
Common Stock
2022-03-10$57.92/sh−2,089$120,995→ 36,210 total - Sale
Common Stock
2022-03-11$58.24/sh−3,634$211,644→ 32,576 total - Exercise/Conversion
Restricted Stock Unit
2022-03-10−3,130→ 17,301 total→ Common Stock (3,130 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.
- [F3]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001739307
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 9:46 PM ET
- Size
- 13.3 KB